TFA
AMED

Transamerica Financial Advisors’s Amedisys AMED Stock Holding History

Transamerica Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed -$1K – 122
2021
Q2 		$1K Buy
+2
New +$525 0.02% 82

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Transamerica Financial Advisors's AMED Position: Q3 2021 in Review

Transamerica Financial Advisors sold out of Amedisys (AMED) in Q3 2021, closing a stake of 2 shares — an estimated $1K sold.

Transamerica Financial Advisors first reported a position in AMED in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Transamerica Financial Advisors reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Transamerica Financial Advisors sold 2 Amedisys shares in Q3 2021, an estimated $1K.
  • Transamerica Financial Advisors first reported a position in Amedisys in Q2 2021 and held it in 1 quarter.
  • Transamerica Financial Advisors's Amedisys position peaked at $1K in Q2 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Transamerica Financial Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.